183 related articles for article (PubMed ID: 6778918)
1. The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.
Schenkein HA; Ruddy S
J Immunol; 1981 Jan; 126(1):7-10. PubMed ID: 6778918
[TBL] [Abstract][Full Text] [Related]
2. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
3. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
Schenkein HA; Ruddy S
J Immunol; 1981 Jan; 126(1):11-5. PubMed ID: 6905857
[No Abstract] [Full Text] [Related]
4. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni.
Ferrante A; Rowan-Kelly B
Clin Exp Immunol; 1983 Nov; 54(2):477-85. PubMed ID: 6418422
[TBL] [Abstract][Full Text] [Related]
5. Activation of the alternative pathway of complement by Entamoeba histolytica.
Ortiz-Ortiz L; Capin R; Capin NR; Sepúlveda B; Zamacona G
Clin Exp Immunol; 1978 Oct; 34(1):10-8. PubMed ID: 219975
[TBL] [Abstract][Full Text] [Related]
6. Activation of the alternative pathway of complement by human peripheral nerve myelin.
Koski CL; Vanguri P; Shin ML
J Immunol; 1985 Mar; 134(3):1810-4. PubMed ID: 2578522
[TBL] [Abstract][Full Text] [Related]
7. Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activation.
Santoro F; Lachmann PJ; Capron A; Capron M
J Immunol; 1979 Oct; 123(4):1551-7. PubMed ID: 113459
[TBL] [Abstract][Full Text] [Related]
8. Kinetic assessment of alternative complement pathway activity in a hemolytic system. II. Influence of antibody on alternative pathway activation.
Polhill RB; Newman SL; Pruitt KM; Johnston RB
J Immunol; 1978 Jul; 121(1):371-6. PubMed ID: 670706
[TBL] [Abstract][Full Text] [Related]
9. Reversal of immune complex inhibition of antibody-dependent cell-mediated cytotoxicity by normal human serum.
Isturiz MA; Fink SB; de Bracco MM
Clin Exp Immunol; 1982 Jun; 48(3):685-92. PubMed ID: 7116689
[TBL] [Abstract][Full Text] [Related]
10. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.
Czop JK; Austen KF
J Immunol; 1985 Nov; 135(5):3388-93. PubMed ID: 4045195
[TBL] [Abstract][Full Text] [Related]
11. Alternative complement pathway-dependent ingestion of fluolite particles by human granulocytes.
Arnaout MA; Luscinskas FW; Lionetti FJ; Alper CA; Valeri CR
J Immunol; 1981 Jul; 127(1):278-81. PubMed ID: 6787126
[TBL] [Abstract][Full Text] [Related]
12. Activation of the alternative pathway of complement by antiserum to factor B.
Wilson MR; Arroyave CM; Tan EM
J Lab Clin Med; 1979 Mar; 93(3):493-8. PubMed ID: 107255
[TBL] [Abstract][Full Text] [Related]
13. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
Gronski P; Bodenbender L; Kanzy EJ; Seiler FR
Behring Inst Mitt; 1984 Nov; (76):29-41. PubMed ID: 6335396
[TBL] [Abstract][Full Text] [Related]
14. Activation of the alternative complement pathway in normal human serum by Loa loa and Brugia malayi infective stage larvae.
Yates JA; Higashi GI; Lowichik A; Orihel TC; Lowrie RC; Eberhard ML
Acta Trop; 1985 Jun; 42(2):157-63. PubMed ID: 2862778
[TBL] [Abstract][Full Text] [Related]
15. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
Inada K
Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
[TBL] [Abstract][Full Text] [Related]
16. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
[TBL] [Abstract][Full Text] [Related]
17. Serotherapy of primary rat mammary carcinoma: inhibition by ethylenedinitrilotetraacetic acid but not by [ethylenebis(oxyethylenenitrilo)]tetraacetic acid.
Nakanishi K; Zbar B; Borsos T; Glenn G
Cancer Res; 1986 Aug; 46(8):3886-90. PubMed ID: 3089581
[TBL] [Abstract][Full Text] [Related]
18. Importance of the integrity of the inter-heavy-chain disulphide bond of rabbit IgG in the activation of the alternative pathway of human complement by the F(ab')2 region of rabbit IgG antibody in immune aggregates.
Gadd KJ; Reid KB
Immunology; 1981 Jan; 42(1):75-82. PubMed ID: 6780451
[TBL] [Abstract][Full Text] [Related]
19. [Role of the classical and alternative complement pathways in chemotaxis of human C2 deficiency (author's transl)].
Pham Huu T; Buriot D; Griscelli C
Ann Immunol (Paris); 1980; 131C(1):69-77. PubMed ID: 7396417
[TBL] [Abstract][Full Text] [Related]
20. Independent effects of IgG and complement upon human polymorphonuclear leukocyte function.
Goldstein IM; Kaplan HB; Radin A; Frosch M
J Immunol; 1976 Oct; 117(4):1282-7. PubMed ID: 185296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
